Event Date/Time: Nov 21, 2013 / 8:00 am - (PST) End Date/Time: Nov 22, 2013 / 5:20 pm - (PST)
Report as Spam

Description

Outsourcing of preclinical development is projected to increase by up to 50% in the next few years. As R&D outsourcing continues to gain momentum, increasing numbers of countries have sought to create an infrastructure that will support discovery through academic innovation and government investment. This has created a scenario where the Asia Pacific region is developing fully outsourced drug discovery programmes from lead identification through to lead optimisation and beyond. With increasing preclinical investment in Asia it is important to seek outsourcing strategies that will minimise risk and maximise returns - to learn critical factors, tips and what to expect.

 

The 3rd congress will build upon the success of last year’s APRADOC and examine how the Asia Pacific region has developed as a potential partner for outsourcing drug discovery programs. With a particular focus on preclinical outsourcing, the conference will centre on the key issues facing those new to and already outsourcing R&D efforts to Asia. Addressing the need to protect intellectual property, keep up to date with continually developing regional regulation and identify partnerships within chemistry, biology and biologics outsourcing; the congress will seek to improve successes and examine best practice techniques, innovative strategies, and business models in order to minimise expenses and develop pipelines during a time of soaring R&D costs.

Venue

500 Hotel Circle North
San Diego
California
United States
MORE INFO ON THIS VENUE

Conference Speakers

Rakesh Dixit, VP R&D, Global Head, Biologics Safety Assessment, MedImmune James Garner, VP & General Manager, Takeda Global Research and Development Center Saryu Goel, Associate Director & Project Leader, Supernus Pharmaceuticals Inc. Raman Govindarajan, Head, India R&D, Sanofi-Aventis Srinivas Kasibhatla, former Head Discovery Chemistry, Bristol Myers Squibb Ying Luo, Chairman, President and Chief Executive Officer, Shanghai Genomics Sylvie Sakata, Senior Director, External Research Solutions West and Asia, Pfizer Stephanie Shi, Integrated Sourcing Lead, Pfizer David Wadsworth, Global Head Small Molecule Research Outsourcing & Operations, F. Hoffmann-La Roche

Additional Information

Rakesh Dixit, VP R&D, Global Head, Biologics Safety Assessment, MedImmune James Garner, VP & General Manager, Takeda Global Research and Development Center Saryu Goel, Associate Director & Project Leader, Supernus Pharmaceuticals Inc. Raman Govindarajan, Head, India R&D, Sanofi-Aventis Srinivas Kasibhatla, former Head Discovery Chemistry, Bristol Myers Squibb Ying Luo, Chairman, President and Chief Executive Officer, Shanghai Genomics Sylvie Sakata, Senior Director, External Research Solutions West and Asia, Pfizer Stephanie Shi, Integrated Sourcing Lead, Pfizer David Wadsworth, Global Head Small Molecule Research Outsourcing & Operations, F. Hoffmann-La Roche